Creekmore, R., Morton, C., Houck, M., Wolfgang, S., Holloway, G., Sheehan, C., Wang, H., The Complexity of Setting Compendial Specifications for Excipient Composition and Impurities, USP Pharmacopeial Forum (PF) 44(3), May–Jun. 2018.
Leane, M., Pitt, K., Reynolds, G., and The Manufacturing Classification System (MCS) Working Group, “A proposal for a drug product Manufacturing Classification System (MCS) for oral solid dosage forms,” Pharmaceutical Development and Technology, August 2014.
Creekmore, R., Dokou, E., Elyath, A., Joiner, D., Lovdahl, M., Jackson Pellett, Eric Schmitt, John W. Skoug, “Early Development GMP’s for Drug-Product Manufacturing of Small Molecules. An Industry Perspective (Part III),” Pharmaceutical Technology 36 (8), pp. 56-61 (August 2012).
Frank, T., Brooks, S., Murray, K., Reich, S., Sanchez, E., Hasselbach, B., Obeng, K., Creekmore, R., “Packaging Line GMP Optimization. A Risk-Management Case Study (Part 6),” Pharmaceutical Technology 35(12), pp. 46-48 (December 2011).
Frank, T., Brooks, S., Murray, K., Reich, S., Sanchez, E., Hasselbach, B., Obeng, K., Creekmore, R., “Nonsterile Facility Cleaning Requirements. A Risk-Management Case Study (Part 5),” Pharmaceutical Technology 35 (11), pp. 72-74, 82 (November 2011).
Frank, T., Brooks, S., Murray, K., Reich, S., Sanchez, E., Hasselbach, B., Obeng, K., Creekmore, R., “Process Deviation and Empty Product Capsules. A Risk-Management Case Study (Part 4),” Pharmaceutical Technology 35 (10), pp. 76-80 (October 2011).
Frank, T., Brooks, S., Murray, K., Reich, S., Sanchez, E., Hasselbach, B., Obeng, K., Creekmore, R., “Facility Biocontainment and Inactivation. A Risk-Management Case Study (Part 3),” Pharmaceutical Technology 35 (9), pp. 74-76 (September 2011).
Frank, T., Brooks, S., Murray, K., Reich, S., Sanchez, E., Hasselbach, B., Obeng, K., Creekmore, R., “Functional Equivalence for Equipment Replacements. A Risk-Management Case Study (Part 2),” Pharmaceutical Technology 35 (8), pp. 72-75 (August 2011).
Frank, T., Brooks, S., Murray, K., Reich, S., Sanchez, E., Hasselbach, B., Obeng, K., Creekmore, R., “Defining Process Design Space. A Risk-Management Case Study (Part 1),” Pharmaceutical Technology 35(7), pp. 77-79 (July 2011).
Frank, T., Brooks, S., Murray, K., Reich, S., Sanchez, E., Hasselbach, B., Obeng, K., Creekmore, R., “Quality Risk Management. Principles and Industry Case Studies,” Pharmaceutical Technology 35(7), pp. 72-76 (July 2011).
Block, L.H., Moreton, R.C, Apte, S.P., Wendt, R.H., Munson, E.J., Creekmore, J.R., Persaud, I.V., Sheehan, C. and Wang, H., Co-processed Excipients, Pharmacopeial Forum, (2009), 35, (4), July–Aug., 1026 – 1028.
Frank, T., Brooks, S., Murray, K., Reich, S., Sanchez, E., Hasselbach, B., Obeng, K., Creekmore, R., "Quality Risk Management Principles and Industry Case Studies", Pharmaceutical Quality Research Institute (PQRI), (December, 2008)
Cogdill, R.P., Forcht, R.N., Shen, Y., Taday, P.F., Creekmore, J.R., Anderson, C.A., and Drennen, J.K., “Comparison of Terahertz Pulse Imaging and Near-Infrared Spectroscopy for Rapid, Non-Destructive Analysis of Tablet Coating Thickness and Uniformity,” Journal of Pharmaceutical Innovation 2 (1 and 2), pp. 29-36 (February 2007).
Creekmore, R., Alexander, A.W., and Brush, P., “PAT in Pharmaceutical Development,” Process Analytical Technology, 3 (2), pp. 18-21 (March/April 2006).
Wurster, D.E., Rowlings, C.E., and Creekmore, J.R. “Calorimetric Analysis of Powder Compression: I. Design and Development of a Compression Calorimeter,” International Journal of Pharmaceutics, 116 (2), pp. 179-189 (April, 1995).
Wurster, D.E. and Creekmore, J.R., "Measurement of the Thermal Energy Evolved Upon Tablet Compression," Drug Development and Industrial Pharmacy, 12(10), pp. 1151-1528 (October, 1986).
Creekmore, J.R., "Measurement of the Thermal Energy Change upon Tablet Compression," Ph.D. Dissertation, The University of Iowa, 1986.
Creekmore, J.R., Kowalski, R.J., Kwock, L., and Wurster, D.E., "Radioiodinated Bleomycin: Stiochiometry of Iodination and Structural Characterization by 1H Nuclear Magnetic Resonance," International Journal of Radiation and Isotopes 35 (3) pp.189 194 (March, 1984).
Creekmore, J.R., "Synthesis and Characterization of Iodinated Bleomycin," Master's Thesis, The University of North Carolina at Chapel Hill, 1982.
Kowalski, R.J. and Creekmore, J.R., "Technical Artifacts in Chromatographic Analysis of Tc 99m Radiopharmaceuticals," Journal of Nuclear Medicine Technology 10(1), pp. 15-19 (March, 1982).
Creekmore Pharma Consulting
101 Winterbury Lane Wilmington Delaware 19808 United States
Copyright © 2020 Creekmore Pharma Consulting - All Rights Reserved.
Powered by GoDaddy Website Builder